LLY Cumulative FCF
The running total of free cash flow across the series, showing cumulative cash generated to date.
Cumulative FCF
Latest: $23.50B (2026Q2)
| Period | Value |
|---|---|
| 2024Q1 | $180M |
| 2024Q2 | $421M |
| 2024Q3 | $2.78B |
| 2024Q4 | $3.76B |
| 2025Q1 | $3.92B |
| 2025Q2 | $5.31B |
| 2025Q3 | $12.05B |
| 2025Q4 | $12.73B |
| 2026Q1 | $15.74B |
| 2026Q2 | $23.50B |
Other LLY Charts
More quarter-by-quarter fundamentals for Eli Lilly and Company
1 / 10
Revenue
EPS
Free Cash Flow
Gross Margin
FCF Margin
P/E Ratio
Shares Outstanding
Total Assets
Total Debt
Rule of 40
Healthcare Comparison
1 / 3
Cumulative FCF
Cumulative FCF
Cumulative FCF
Latest Cumulative FCF: $23.50B (2026Q2); +342.8% YoY.
Across the 10 quarters from 2024Q1 to 2026Q2, Cumulative FCF ranged from $180M in 2024Q1 to $23.50B in 2026Q2.